Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Nancie M. Archin, Abigail Liberty, Angela D. M. Kashuba et al. · Nature · 2012 · 1.2K citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

Olivier Schwartz, Valerie Maréchal, Sylvie Le Gall et al. · Nature Medicine · 1996 · 1.1K citations

Life Sciences, Cell Biology, Immunology +12

HIV‐1 replication is controlled at the level of T cell activation and proviral integration.

Mario Stevenson, Trevor L. Stanwick, Michael P. Dempsey et al. · The EMBO Journal · 1990 · 794 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

Liang Shan, Kai Deng, Neeta S. Shroff et al. · Immunity · 2012 · 707 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Kristina Allers, Gero Hütter, Jörg Hofmann et al. · Blood · 2010 · 681 citations

Life Sciences, Immunology, Infectious Diseases +10